PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50121F33010 — THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL is a federal award for Department of Health and Human Services (HHS) held by SEQIRUS INC.. Estimated value $35M ($21.4M obligated). Current period of performance ends Jan 31, 2027. Last award drew 2 bidders.

$35M
Estimated Value
$21.4M
Obligated
Jan 31, 2027
PoP End / Expires
2
Bidders (last award)
SEQIRUS INC.
Incumbent

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

SEQIRUS INC. holds $419.6M across 33 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 2 offers. Recompete timing centers on the Jan 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

Federal
Contract number75A50121F33010
AgencyDepartment of Health and Human Services (HHS)
IncumbentSEQIRUS INC.
UEIZ6N1LJ2RD6E3
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN14
Parent IDIQ / IDV75A50118D00004
PoP end (current)Jan 31, 2027
Obligated$21.4M

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL

Recompete timing

Public
Expiring in 168 days

Current PoP ends Jan 31, 2027 (168 days remaining). Agencies typically plan 12–18 months ahead — at 5.5 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

SEQIRUS INC.$419.6M obligated across 33 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$419.6M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75A50121F33010
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open SEQIRUS INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50121F33010?

75A50121F33010 (THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL) is a Department of Health and Human Services (HHS) award with an estimated value of $35M, currently held by SEQIRUS INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50121F33010?

SEQIRUS INC. is the incumbent with $419.6M across 33 related awards in SCOUT’s public footprint. The current period of performance ends Jan 31, 2027.

When does 75A50121F33010 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50118D00004-75A50121F33010